Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential applications. Early findings suggest that this higher dosage may enhance the drug's ability to regulate blood glucose, potentially offering more significant outcomes for individuals with insulin resistance. Further research is underway to fully evalua